Alongside medication, the program includes ongoing behavioral support, nutritional guidance, exercise counseling, and continuous medical monitoring
Nausea: the most common early experience Nausea is the most frequently reported side effect with retatrutide, occurring in 14% of participants at 1mg up to 60% at 12mg in clinical trials
After receiving an injection, some people experience symptoms at the injection site on the skin
were interested in creating the former while curbing the latter as much as possible
To minimize risk, estradiol patches should be used at the lowest effective dose for the shortest duration necessary, under the guidance of a healthcare provider
The role of the coagulation system in peripheral arterial disease: interactions with the Arterial Wall and its vascular microenvironment and implications for rational therapies